Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revvity, Inc. Common Stock
(NY:
RVTY
)
96.36
-0.09 (-0.09%)
Streaming Delayed Price
Updated: 10:10 AM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revvity, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group
February 20, 2025
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
February 20, 2025
From
Revvity
Via
Business Wire
Uncover the latest developments among S&P500 stocks in today's session.
February 10, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations
January 31, 2025
Life sciences company Revvity (NYSE:RVTY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.8% year on year to $729.4 million. On the other hand, the company’s full-year revenue...
Via
StockStory
(RVTY) - Analyzing Revvity's Short Interest
January 22, 2025
Via
Benzinga
Forecasting The Future: 7 Analyst Projections For Revvity
January 21, 2025
Via
Benzinga
Friday's pre-market session: top gainers and losers in the S&P500 index
January 31, 2025
Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.
Via
Chartmill
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024
January 31, 2025
From
Revvity
Via
Business Wire
Earnings Scheduled For January 31, 2025
January 31, 2025
Via
Benzinga
These Analysts Revise Their Forecasts On Revvity Following Q3 Results
November 05, 2024
Via
Benzinga
Assessing Revvity: Insights From 8 Financial Analysts
October 15, 2024
Via
Benzinga
Looking Into Revvity's Recent Short Interest
September 10, 2024
Via
Benzinga
Revvity Board Declares Quarterly Dividend
January 23, 2025
From
Revvity
Via
Business Wire
Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing
January 13, 2025
From
Revvity
Via
Business Wire
Revvity to Hold Earnings Call on Friday, January 31, 2025; Provides Update on Financial Performance
January 12, 2025
From
Revvity
Via
Business Wire
Revvity Announces FDA Clearance for First Automated Free Testosterone Test
January 10, 2025
From
Revvity
Via
Business Wire
Revvity to Present at J.P. Morgan Healthcare Conference
December 17, 2024
From
Revvity
Via
Business Wire
Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst
December 13, 2024
BofA upgrades Danaher and Revvity, predicting a mixed but improving outlook for life sciences tools in fiscal year 2025 amid ongoing market challenges.
Via
Benzinga
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
November 20, 2024
From
Revvity
Via
Business Wire
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
November 19, 2024
From
Scale Biosciences
Via
Business Wire
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
November 19, 2024
From
Revvity
Via
Business Wire
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
November 18, 2024
From
Revvity
Via
Business Wire
Revvity Announces Financial Results for the Third Quarter of 2024
November 04, 2024
From
Revvity
Via
Business Wire
Revvity Board Declares Quarterly Dividend
October 24, 2024
From
Revvity
Via
Business Wire
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
October 22, 2024
From
Revvity
Via
Business Wire
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
October 22, 2024
From
Revvity
Via
Business Wire
Revvity To Hold Earnings Call on Monday, November 4, 2024
October 07, 2024
From
Revvity
Via
Business Wire
Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
October 02, 2024
From
Revvity
Via
Business Wire
Revvity to Present at Upcoming Investor Conferences
August 21, 2024
From
Revvity
Via
Business Wire
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
July 29, 2024
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events.
Via
Benzinga
Topics
Economy
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.